Bon Natural Life (BON) Competitors $0.06 -0.01 (-12.81%) Closing price 04:00 PM EasternExtended Trading$0.06 0.00 (-0.63%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrendsBuy This Stock BON vs. VAXX, BIOR, RNAZ, ADTX, SRNE, TFFP, TCBP, KRBP, HSTO, and HEPAShould you be buying Bon Natural Life stock or one of its competitors? The main competitors of Bon Natural Life include Vaxxinity (VAXX), Biora Therapeutics (BIOR), TransCode Therapeutics (RNAZ), Aditxt (ADTX), Sorrento Therapeutics (SRNE), TFF Pharmaceuticals (TFFP), TC Biopharm (TCBP), Kiromic BioPharma (KRBP), Histogen (HSTO), and Hepion Pharmaceuticals (HEPA). These companies are all part of the "pharmaceutical products" industry. Bon Natural Life vs. Vaxxinity Biora Therapeutics TransCode Therapeutics Aditxt Sorrento Therapeutics TFF Pharmaceuticals TC Biopharm Kiromic BioPharma Histogen Hepion Pharmaceuticals Bon Natural Life (NYSE:BON) and Vaxxinity (NASDAQ:VAXX) are both small-cap consumer discretionary companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, earnings, community ranking, valuation, analyst recommendations, media sentiment, dividends, profitability and risk. Which has preferable valuation & earnings, BON or VAXX? Bon Natural Life has higher revenue and earnings than Vaxxinity. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBon Natural Life$23.84M0.01$400KN/AN/AVaxxinityN/AN/A-$56.93M-$0.45-0.11 Do institutionals and insiders have more ownership in BON or VAXX? 0.6% of Bon Natural Life shares are held by institutional investors. Comparatively, 82.9% of Vaxxinity shares are held by institutional investors. 26.5% of Bon Natural Life shares are held by insiders. Comparatively, 64.1% of Vaxxinity shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has more volatility and risk, BON or VAXX? Bon Natural Life has a beta of -1.09, meaning that its share price is 209% less volatile than the S&P 500. Comparatively, Vaxxinity has a beta of -17.57, meaning that its share price is 1,857% less volatile than the S&P 500. Does the media prefer BON or VAXX? In the previous week, Bon Natural Life's average media sentiment score of 0.00 equaled Vaxxinity'saverage media sentiment score. Company Overall Sentiment Bon Natural Life Neutral Vaxxinity Neutral Does the MarketBeat Community favor BON or VAXX? Vaxxinity received 5 more outperform votes than Bon Natural Life when rated by MarketBeat users. CompanyUnderperformOutperformBon Natural LifeN/AN/AVaxxinityOutperform Votes538.46% Underperform Votes861.54% Is BON or VAXX more profitable? Company Net Margins Return on Equity Return on Assets Bon Natural LifeN/A N/A N/A Vaxxinity N/A N/A N/A SummaryBon Natural Life and Vaxxinity tied by winning 3 of the 6 factors compared between the two stocks. Remove Ads Get Bon Natural Life News Delivered to You Automatically Sign up to receive the latest news and ratings for BON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BON vs. The Competition Export to ExcelMetricBon Natural LifeMedicinals & botanicals IndustryDiscretionary SectorNYSE ExchangeMarket Cap$251,000.00$1.17B$7.21B$18.89BDividend YieldN/AN/A2.99%3.79%P/E RatioN/A9.6215.7731.43Price / Sales0.015.8110.5925.45Price / Cash0.7810.4016.4217.54Price / Book0.001.154.124.36Net Income$400,000.00-$56.07M$259.47M$1.02B7 Day PerformanceN/A-8.27%-6.71%-5.42%1 Month PerformanceN/A-15.41%-7.84%-5.81%1 Year PerformanceN/A-47.30%-8.97%-0.44% Bon Natural Life Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BONBon Natural LifeN/A$0.06-12.8%N/A-98.3%$251,000.00$23.84M0.00100Gap DownHigh Trading VolumeVAXXVaxxinityN/A$0.01-50.0%N/A-100.0%$634,000.00N/A-0.0190Gap DownBIORBiora Therapeutics2.4158 of 5 stars$0.13+0.2%$23.00+17,538.0%-97.8%$590,000.00$892,000.00-0.01120Gap UpRNAZTransCode Therapeutics2.5341 of 5 stars$0.69-38.2%$20.00+2,787.3%-99.9%$482,000.00N/A0.009Upcoming EarningsGap DownHigh Trading VolumeADTXAditxt0.8303 of 5 stars$7.17-25.5%N/A-100.0%$409,000.00$212,107.000.0060Gap DownSRNESorrento TherapeuticsN/A$0.00flatN/A-88.0%$386,000.00$60.32M0.00800Analyst ForecastTFFPTFF PharmaceuticalsN/A$0.07flat$44.00+67,592.3%N/A$289,000.00$-70,983.00-0.0119TCBPTC Biopharm2.0383 of 5 stars$0.68-55.8%$48.00+6,948.5%-99.7%$279,000.00$4.76M0.0080Upcoming EarningsHigh Trading VolumeKRBPKiromic BioPharmaN/A$0.16-48.7%N/AN/A$252,000.00N/A-0.0560Gap DownHigh Trading VolumeHSTOHistogenN/A$0.03flatN/AN/A$133,000.00$19,000.00-0.0120HEPAHepion Pharmaceuticals0.3616 of 5 stars$0.74-7.2%N/A-99.6%$103,000.00N/A-0.1720Gap UpHigh Trading Volume Remove Ads Related Companies and Tools Related Companies Vaxxinity Competitors Biora Therapeutics Competitors TransCode Therapeutics Competitors Aditxt Competitors Sorrento Therapeutics Competitors TFF Pharmaceuticals Competitors TC Biopharm Competitors Kiromic BioPharma Competitors Histogen Competitors Hepion Pharmaceuticals Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:BON) was last updated on 4/3/2025 by MarketBeat.com Staff From Our Partners“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredNew “Trump” currency proposed in DCAfter a massive run-up – tech stocks are crashing. And as you’d suspect, the rich and powerful got out firs...Paradigm Press | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bon Natural Life Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Bon Natural Life With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy BON Stock Free BON Stock Alerts